What is the recommended protocol for tapering vasopressin infusion in a hemodynamically stable patient without active bleeding or severe adrenal insufficiency?

Vasopressin Tapering Protocol

In hemodynamically stable patients recovering from shock, vasopressin should be tapered by decreasing the dose by 0.005 units/minute every hour after the target blood pressure has been maintained for 8 hours without catecholamines, and can be discontinued abruptly once weaned to low doses without increased risk of hypotension compared to gradual discontinuation. 1

Recommended Tapering Approach

When to Begin Tapering

• Start tapering after target MAP has been maintained for 8 hours without requiring catecholamines 1
• Ensure hemodynamic stability with adequate tissue perfusion markers (lactate clearance, urine output, mental status)
• Confirm no ongoing bleeding or severe adrenal insufficiency

Tapering Protocol (FDA-Approved)

The FDA label provides explicit guidance 1:

• Decrease vasopressin by 0.005 units/minute increments
• Taper every hour as tolerated
• Continue tapering to maintain target blood pressure
• This applies after reaching therapeutic doses (typically 0.01-0.03 units/minute in septic shock)

Order of Discontinuation: Vasopressin vs Norepinephrine

Vasopressin should generally be discontinued AFTER norepinephrine is weaned, based on the protocols used in major trials (VASST, VANISH) where withdrawing vasopressin first was associated with more hemodynamic instability 2. However, recent high-quality evidence challenges this dogma:

• A 2025 propensity-weighted study of 524 ICU patients found no significant difference in hypotension rates whether vasopressin or norepinephrine was discontinued first (19% vs 21%, P=0.59) when baseline characteristics and end doses were properly balanced 3
• The key factor is the end dose in norepinephrine equivalents, not the order of discontinuation

Practical Algorithm:

1. Wean norepinephrine first if vasopressin dose is ≤0.03 units/minute (traditional approach)
2. If both agents are at low doses, either can be discontinued first based on clinical context
3. Monitor closely for 24 hours after discontinuation regardless of order

Abrupt vs Gradual Discontinuation

Once vasopressin is tapered to low doses, abrupt discontinuation is safe and may be preferable 4:

• A 2021 multicenter study of 1,318 septic shock patients found no difference in time to ICU discharge between abrupt discontinuation (73% of patients) versus down-titration (27% of patients)
• No difference in ICU mortality (21.8% vs 18.0%, P=0.13) or hospital mortality (28.9% vs 31.1%, P=0.44)
• Incidence of hypotension was similar (39.7% vs 41.7%, P=0.53)
• Abrupt discontinuation resulted in shorter vasopressin duration (1.4 vs 1.8 days, P<0.001)
• Down-titration group more frequently required re-escalation of vasopressin (11.1% vs 5.7%, P<0.001)

Monitoring During Tapering

Essential Parameters

• Continuous arterial blood pressure monitoring (intra-arterial line recommended) 5, 2
• Mean arterial pressure (target ≥65 mmHg)
• Heart rate and cardiac rhythm
• Urine output (goal >0.5 mL/kg/hour)
• Lactate levels (trending downward)
• Mental status
• Skin perfusion and temperature

Signs Requiring Pause or Reversal of Tapering

• MAP drops below 60 mmHg
• Urine output decreases significantly
• Lactate begins rising
• New arrhythmias develop
• Mental status deteriorates
• Signs of end-organ hypoperfusion

Critical Pitfalls to Avoid

1. Do not use vasopressin as a single agent during weaning - It should always be used in combination with norepinephrine, never titrated alone 6

2. Maximum dose considerations - Doses above 0.04 units/minute should be reserved for salvage therapy only 5

3. Avoid premature discontinuation - Ensure 8 hours of hemodynamic stability first 1

4. Watch for rebound hypotension - The pressor effect fades within 20 minutes after stopping infusion 1

5. Consider adrenal function - In patients on concurrent hydrocortisone, taper steroids when vasopressors are no longer required 5. Undiagnosed adrenal insufficiency can complicate vasopressin weaning 7

6. Avoid excessive caution - Clinicians often maintain higher blood pressures than necessary or continue supra-therapeutic doses, overestimating re-aggravation risk 2

Special Considerations

Septic Shock Context

The Surviving Sepsis Campaign guidelines frame vasopressin use as an adjunct to norepinephrine (up to 0.03 units/minute) to either raise MAP to target or decrease norepinephrine requirements 5. The same principles apply during weaning - vasopressin serves to facilitate norepinephrine reduction.

Computerized Weaning

Computerized-assisted weaning protocols may reduce unnecessary exposure to vasoactive drugs 2, though specific protocols for vasopressin are not well-established.